Still deciding whether to register for the upcoming Explorers Course 2026?Take a moment to watch these highlights shared by attendees from the previous course.Their firsthand experiences offer valuable insight — and demonstrate why the Explorers Course 2026 is one you…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here:




